Synthesis and in vitro antiplatelet activity of new 4-(1-piperazinyl)coumarin derivatives. Human platelet phosphodiesterase 3 inhibitory properties of the two most effective compounds described and molecular modeling study on their interactions with phosphodiesterase 3A catalytic site.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2007-05-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM0611511PMID 17500510
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lessons in molecular recognition: the effects of ligand and protein flexibility on molecular docking accuracy.

  2004cited by this paper
• Mechanisms involved in the antiplatelet activity of 8-methyl-4-(1-piperazinyl)-7-(3-pyridinylmethoxy)-2H-1-benzopyran-2-one (RC414).

  2004cited by this paper
• Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins.

  2004cited by this paper
• Coumarin, chromone, and 4(3H)-pyrimidinone novel bicyclic and tricyclic derivatives as antiplatelet agents: synthesis, biological evaluation, and comparative molecular field analysis.

  2003cited by this paper
• Structural basis for selective PDE 3 inhibition: a docking study

  2002cited by this paper
• Identification of overlapping but distinct cAMP and cGMP interaction sites with cyclic nucleotide phosphodiesterase 3A by site‐directed mutagenesis and molecular modeling based on crystalline PDE4B

  2001cited by this paper
• Cyclic nucleotide phosphodiesterases.

  2001cited by this paper
• Synthesis, antiplatelet activity and comparative molecular field analysis of substituted 2-amino-4H-pyrido[1,2-a]pyrimidin-4-ones, their congeners and isosteric analogues.

  2000cited by this paper
• Chemistry of Substituted Quinolinones. Part VI. † Synthesis and Nucleophilic Reactions of 4-Chloro-8-methylquinolin-2(1H)-one and its Thione Analogue

  2000cited by this paper
• Effect of 2-(1-piperazinyl)-4H-pyrido[1,2-a]pyrimidin-4-one (AP155) on human platelets in vitro.

  1997cited by this paper
• 1,2-Fused pyrimidines. VII: 3-(dialkylamino)-1H-pyrimido[1,2-a]quinolin-1-ones and 2-(dialkylamino)-4H-pyrimido[2,1-a]isoquinolin-4-ones as antiplatelet compounds

  1995cited by this paper
• Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms.

  1995cited by this paper
• Pyran derivatives XIX. (Dialkylamino) substituted 1-benzopyranones and naphthopyranones with platelet antiaggregating activity.

  1995cited by this paper
• 1,2-fused pyrimidines. VI. Substituted 2-amino-4H-pyrido[1,2-a]pyrimidin-4-ones with antiplatelet activity.

  1993cited by this paper
• Pharmacological manipulation of tissue cyclic AMP by inhibitors. Effects of phosphodiesterase inhibitors on the functions of platelets and vascular endothelial cells.

  1992cited by this paper
• Antiplatelet effect of 2-(diethylamino)-7-hydroxychromone.

  1991cited by this paper
• Macromodel—an integrated software system for modeling organic and bioorganic molecules using molecular mechanics

  1990cited by this paper
• Synthesis and antiplatelet activity of 2-(diethylamino)-7-ethoxychromone and related compounds

  1990cited by this paper
• Synthesis and anti-platelet activity of some 2-(dialkylamino)chromones

  1988cited by this paper
• Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets. Isolation, characterization, and effects of various reference phosphodiesterase inhibitors and cardiotonic agents.

  1986cited by this paper
• Regulation of cyclic AMP metabolism in human platelets. Sequential activation of adenylate cyclase and cyclic AMP phosphodiesterase by prostaglandins.

  1981cited by this paper
• Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

  1962cited by this paper
• Phosphorylase activity in haemic cells.

  1962cited by this paper
• Antimalarials; 7-chloro-4-hydroxy- and 4,7-dichloro-1-methylcarbostyrils.

  1946cited by this paper
• Antimalarials; 7-chloro-4-hydroxy- and 4,7-dichloro-1-methylcarbostyrils.

  1946cited by this paper

• The effect of bisphenol PH and seven other bisphenol A alternatives on human haemostasis in vitro.

  2025cites this paper
• Design, synthesis of some novel coumarins and their nanoformulations into lipid-chitosan nanocapsule as unique antimicrobial agents

  2024cites this paper
• Evaluation of the antiplatelet effect of generic ticagrelor 90 mg (ticaspan®) alone and in combination with aspirin 75 mg as compared to ticagrelor (innovator): An in vitro study

  2023cites this paper
• Synthetic coumarin derivatives with anticoagulation and antiplatelet aggregation inhibitory effects

  2023influential citation
• Miniscule modification of coumarin-based potential biomaterials: Synthesis, characterization, computational and biological studies

  2023cites this paper
• The antithrombotic activity of natural and synthetic coumarins.

  2021cites this paper
• Progress of thrombus formation and research on the structure-activity relationship for antithrombotic drugs.

  2021cites this paper
• Design, synthesis and in vivo evaluation of 3-arylcoumarin derivatives of rhenium(I) tricarbonyl complexes as potent antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA).

  2020cites this paper
• Syntheses and Evaluation of 2- or 3-(N-Cyclicamino)chromone Derivatives as Monoamine Oxidase Inhibitors.

  2020cites this paper
• Synthesis of 1-(Indol-2-yl)-phenoxazine hybrids from quinacetophenone precursors and their biological evaluation as DNA intercalating agents

  2020cites this paper
• Design, Synthesis, Docking Study and Antiplatelet Evaluation of New Thiosemicarbazide Derivatives Derived from Captopril

  2019cites this paper
• Novel compounds of hybrid structure pyridazinone-coumarin as potent inhibitors of platelet aggregation.

  2019cites this paper
• Quinacetophenone: a simple precursor for synthesis of phenoxazines

  2019cites this paper
• Synthesis and discovery of new compounds bearing coumarin scaffold for the treatment of pulmonary fibrosis.

  2019cites this paper
• Non‐peptide‐based new class of platelet aggregation inhibitors: Design, synthesis, bioevaluation, SAR, and in silico studies

  2018cites this paper
• An efficient synthesis and biological evaluation of novel analogues of natural product Cephalandole A: A new class of antimicrobial and antiplatelet agents.

  2018cites this paper
• Synthesis and biological evaluation of pyrano[2,3-f]chromene-4,8-dione derivatives as potential anticancer agents

  2017cites this paper
• Design and Microwave Assisted Synthesis of Coumarin Derivatives as PDE Inhibitors

  2016cites this paper
• Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases.

  2016cites this paper
• Biological importance of structurally diversified chromenes.

  2016cites this paper
• Comparative Study of Microwave-assisted and ConventionalSynthesis of 3-[1-(s-phenylimino) Ethyl]-2H-chromen-2-ones andSelected Hydrazone Derivatives

  2016cites this paper
• Cardiovascular effects of coumarins besides their antioxidant activity.

  2015cites this paper
• Quinacetophenone: A simple precursor to privileged organic motifs

  2015cites this paper
• Design and synthesis of novel 2H-chromen-2-one derivatives bearing 1,2,3-triazole moiety as lead antimicrobials.

  2014cites this paper
• Design, Synthesis, Biological Evaluation, and Molecular Modeling of Coumarin–Piperazine Derivatives as Acetylcholinesterase Inhibitors

  2013cites this paper
• Synthesis, in vitro antiplatelet activity and molecular modelling studies of 10-substituted 2-(1-piperazinyl)pyrimido[1,2-a]benzimidazol-4(10H)-ones.

  2013cites this paper
• Synthesis and cytotoxic activity of non-naturally substituted 4-oxycoumarin derivatives.

  2012cites this paper
• Synthesis and Antibacterial Activities of Novel 4-Hydroxy-7-hydroxy- and 3-Carboxycoumarin Derivatives

  2012cites this paper
• Design and synthesis of condensed thienocoumarins by Suzuki–Miyaura reaction/lactonization tandem protocol

  2012cites this paper
• Synthesis, antimicrobial and DNA cleavage studies of some 4-aryloxymethylcoumarins obtained by reaction of 4-bromomethylcoumarins with bidentate nucleophiles

  2012cites this paper
• In vitro platelet antiaggregatory properties of 4-methylcoumarins.

  2012cites this paper
• 4-Chloro-3-(trifluoroacetyl)coumarin as a novel building block for the synthesis of 7-(trifluoromethyl)-6H-chromeno[4,3-b]quinolin-6-ones

  2011cites this paper
• Synthesis and evaluation as PDE4 inhibitors of pyrimidine‐2,4‐dione derivatives

  2011cites this paper
• Microwave‐assisted synthesis and evaluation of antimicrobial activity of 3‐{3‐(s‐aryl and s‐heteroaromatic)acryloyl}‐2H‐chromen‐2‐one derivatives

  2010cites this paper
• Synthesis and antimicrobial, acetylcholinesterase and butyrylcholinesterase inhibitory activities of novel ester and hydrazide derivatives of 3 (2H)-pyridazinone

  2010cites this paper